Review article · 2015 · Open access

CCR5 Targeted Cell Therapy for HIV and Prevention of Viral Escape

Gero Hütter, Josef Bodor, Scott Ledger, Maureen P. Boyd, Michelle Millington, Marlene S. Tsie, Geoff P. Symonds

Viruses, 7(8), 4186–4203 · Published 27 July 2015 · DOI 10.3390/v7082816

Open PDFView at the publisherCite this paper

In brief

“CCR5 Targeted Cell Therapy for HIV and Prevention of Viral Escape” is a 2015 review article by Gero Hütter and 6 co-authors, published in Viruses. OpenAlex counts 106 citations as of 19 November 2026, which puts it in the top 7% of works published in 2015 by citations. It is open access under a CC BY licence: the full text is free to read at Viruses.

Citations
106
Most cited in
2018 (21)
Field-weighted impact
1.59
References
70
Authors
7

Abstract

Allogeneic transplantation with CCR5-delta 32 (CCR5-d32) homozygous stem cells in an HIV infected individual in 2008, led to a sustained virus control and probably eradication of HIV. Since then there has been a high degree of interest to translate this approach to a wider population. There are two cellular ways to do this. The first one is to use a CCR5 negative cell source e.g., hematopoietic stem cells (HSC) to copy the initial finding. However, a recent case of a second allogeneic transplantation with CCR5-d32 homozygous stem cells suffered from viral escape of CXCR4 quasi-species. The second way is to knock down CCR5 expression by gene therapy. Currently, there are five promising techniques, three of which are presently being tested clinically. These techniques include zinc finger nucleases (ZFN), clustered regularly interspaced palindromic repeats/CRISPR-associated protein 9 nuclease (CRISPR/Cas9), transcription activator-like effectors nuclease (TALEN), short hairpin RNA (shRNA), and a ribozyme. While there are multiple gene therapy strategies being tested, in this review we reflect on our current knowledge of inhibition of CCR5 specifically and whether this approach allows for consequent viral escape.

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Hütter, G., Bodor, J., Ledger, S., Boyd, M. P., Millington, M., Tsie, M. S., & Symonds, G. P. (2015). CCR5 Targeted Cell Therapy for HIV and Prevention of Viral Escape. Viruses, 7(8), 4186–4203. https://doi.org/10.3390/v7082816

MLA 9

Hütter, Gero, et al. “CCR5 Targeted Cell Therapy for HIV and Prevention of Viral Escape.” Viruses, vol. 7, no. 8, 2015, pp. 4186–4203. https://doi.org/10.3390/v7082816.

Chicago

Hütter, Gero, Josef Bodor, Scott Ledger, Maureen P. Boyd, Michelle Millington, Marlene S. Tsie, and Geoff P. Symonds. 2015. “CCR5 Targeted Cell Therapy for HIV and Prevention of Viral Escape.” Viruses 7 (8): 4186–4203. https://doi.org/10.3390/v7082816.

Harvard

Hütter, G. et al. (2015) ‘CCR5 Targeted Cell Therapy for HIV and Prevention of Viral Escape’, Viruses, 7(8), pp. 4186–4203. doi:10.3390/v7082816.

IEEE

G. Hütter et al., “CCR5 Targeted Cell Therapy for HIV and Prevention of Viral Escape,” Viruses, vol. 7, no. 8, pp. 4186–4203, 2015, doi: 10.3390/v7082816.

BibTeX

@article{hutter2015targeted,
  title     = {{CCR5 Targeted Cell Therapy for HIV and Prevention of Viral Escape}},
  author    = {Hütter, Gero and Bodor, Josef and Ledger, Scott and Boyd, Maureen P. and Millington, Michelle and Tsie, Marlene S. and Symonds, Geoff P.},
  journal   = {Viruses},
  year      = {2015},
  volume    = {7},
  number    = {8},
  pages     = {4186--4203},
  doi       = {10.3390/v7082816},
  url       = {https://doi.org/10.3390/v7082816}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Citations by year

YearCitationsShare of the best year
201799
20182121
20191313
20201515
20211111
202288
202344
202455
202522
202622

Its field-weighted citation impact is 1.59: it has been cited 1.59 times as often as the average work of the same field, type and year (1.00 is the world average).

Topic and keywords

Life Sciences › Immunology and Microbiology › Virology › HIV Research and Treatment

  • CCR5
  • HIV
  • CCR5Δ32
  • allogeneic stem cell transplantation
  • viral immune evasion
  • CXCR4
  • hematopoietic stem cells
  • gene therapy

Work with this paper

Most-cited papers in Immunology and Microbiology

All highly cited Immunology and Microbiology papers

Questions about this paper

How do I cite this paper in APA style?

Hütter, G., Bodor, J., Ledger, S., Boyd, M. P., Millington, M., Tsie, M. S., & Symonds, G. P. (2015). CCR5 Targeted Cell Therapy for HIV and Prevention of Viral Escape. Viruses, 7(8), 4186–4203. https://doi.org/10.3390/v7082816

How many times has this paper been cited?

106 times, according to OpenAlex on 19 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

Yes. It is open access at Viruses: sign in and open the PDF from this page.

Who wrote this paper?

Gero Hütter, Josef Bodor, Scott Ledger, Maureen P. Boyd, Michelle Millington, Marlene S. Tsie, Geoff P. Symonds.

What is the DOI of this paper?

10.3390/v7082816, permanently at https://doi.org/10.3390/v7082816. Sign in and open it from this page.

Bibliographic data from OpenAlex (CC0), last checked 19 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.